BiotechTube
Home/Regenesis/Scott Steinman
SS

Scott Steinman

Vice President and Chief Financial Officer

Regenesis

Therapeutic Areas

Chronic PainMusculoskeletal DisordersDiabetic Neuropathy

Regenesis Pipeline

DrugIndicationPhase
Reprieve for Diabetic Peripheral NeuropathyDiabetic Peripheral Neuropathy PainPost-Market
Reprieve for Plantar FasciitisPlantar Fasciitis PainPost-Market
Reprieve for Musculoskeletal PainGeneral Musculoskeletal Pain (e.g., Lumbar)Post-Market

Leadership Team at Regenesis

TE
Tom Eisiminger, Jr.
President & Chief Executive Officer
ET
Erica Tassone, PhD
Vice President, Research & Development
MR
Mary Ritz, PhD
Co-Founder, former President & CEO
FG
Frank George, PhD
Co-Founder
View full Regenesis profile